|
|
Volumn 23, Issue 4, 2009, Pages 343-345
|
|
Beyond psychoanaleptics -can we improve antidepressant drug nomenclature?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGOMELATINE;
AMFEBUTAMONE;
AMITRIPTYLINE;
AMOXAPINE;
ANTIDEPRESSANT AGENT;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CENTRAL STIMULANT AGENT;
CLOMIPRAMINE;
DESIPRAMINE;
DOSULEPIN;
DOXEPIN;
IMIPRAMINE;
LOFEPRAMINE;
LUAA 21004;
MIRTAZAPINE;
MOCLOBEMIDE;
MONOAMINE OXIDASE A INHIBITOR;
MONOAMINE OXIDASE B INHIBITOR;
MONOAMINE OXIDASE INHIBITOR;
NOMIFENSINE;
NOOTROPIC AGENT;
NORTRIPTYLINE;
PHENELZINE;
PROTRIPTYLINE;
REBOXETINE;
SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
TRAZODONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRIMIPRAMINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
DRUG CLASSIFICATION;
DRUG MECHANISM;
DRUG NOMENCLATURE;
EDITORIAL;
HUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
ANTIDEPRESSIVE AGENTS;
DRUG DELIVERY SYSTEMS;
TERMINOLOGY AS TOPIC;
WORLD HEALTH ORGANIZATION;
|
|
EID: 65649133543
PISSN: 02698811
EISSN: 14617285
Source Type: Journal
DOI: 10.1177/0269881109105498 Document Type: Editorial |
|
Times cited : (35)
|
|
References (0)
|
